Cubicin (Royalty rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Cubicin (Royalty rights) General Information

Description

A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Acquirer
Royalty Pharma
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cubicin (Royalty rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cubicin (Royalty rights)‘s full profile, request access.

Request a free trial